PCV13 for older adults

PCV13 shows moderate overall effectiveness for preventing invasive pneumococcal disease caused by PCV13 vaccine serotypes in adults 65 years and older. Also today, ED visits that are related to psychiatric complaints are up 20 among elderly, nonobstructive angina should trigger functional testing, and antibiotics trigger proteolytic activity that leads to chronic colitis.
Amazon Alexa
Apple Podcasts
Spotify